Document is current
Any future updates will be listed below
-
Authors
Kodali, Srikanth https://orcid.org/0000-0001-9330-9880
Proietti, Ludovica https://orcid.org/0000-0002-3077-0079
Valcarcel, Gemma https://orcid.org/0000-0003-0494-9128
López-Rubio, Anna V. https://orcid.org/0000-0001-8664-6205
Pessina, Patrizia https://orcid.org/0000-0002-4227-411X
Eder, Thomas https://orcid.org/0000-0002-0932-2052
Shi, Junchao https://orcid.org/0000-0002-1548-5069
Jen, Annie https://orcid.org/0000-0001-5569-8387
Lupión-Garcia, Núria https://orcid.org/0000-0001-6493-9293
Starner, Anne C.
Bartels, Mason D.
Cui, Yingzhi https://orcid.org/0009-0005-8475-3361
Sands, Caroline M. https://orcid.org/0000-0002-3232-7716
Planas-Riverola, Ainoa
Martínez, Alba https://orcid.org/0000-0001-7514-260X
Velasco-Hernandez, Talia https://orcid.org/0000-0003-2183-7443
Tomás-Daza, Laureano https://orcid.org/0000-0002-6127-1694
Alber, Bernhard https://orcid.org/0000-0002-7601-4826
Manhart, Gabriele
Mayer, Isabella Maria https://orcid.org/0000-0002-9164-9547
Kollmann, Karoline https://orcid.org/0000-0002-7937-4245
Fatica, Alessandro https://orcid.org/0000-0002-0743-7905
Menendez, Pablo
Shishkova, Evgenia
Rau, Rachel E.
Javierre, Biola M. https://orcid.org/0000-0002-8682-6748
Coon, Joshua https://orcid.org/0000-0002-0004-8253
Chen, Qi https://orcid.org/0000-0001-6353-9589
Van Nostrand, Eric L. https://orcid.org/0000-0002-5188-0082
Sardina, Jose L. https://orcid.org/0000-0002-8493-3937
Grebien, Florian https://orcid.org/0000-0003-4289-2281
Di Stefano, Bruno https://orcid.org/0000-0003-2532-3087
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RR200079, RR200040)
American Society of Hematology
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (1R35GM147126-01, 1F32CA288043-01, 5T32DK060445-19)
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (CP22/00127, CP19/00176)
Worldwide Cancer Research (20-0269)
Austrian Science Fund (P-35628, P35298)
- License Information
-
More Information
Article History
Received: 18 September 2023
Accepted: 18 July 2024
First Online: 21 August 2024
Competing interests
: E.V.N. is co-founder, member of the Board of Directors, on the SAB, equity holder and paid consultant for Eclipse BioInnovations, on the SAB of RNAConnect and is inventor of intellectual property owned by University of California San Diego. The interests of E.V.N. have been reviewed and approved by the Baylor College of Medicine in accordance with its conflict of interest policies. P.M. is a co-founder, member of the Board of Directors, equity holder and paid consultant for OneChain Immunotherapeutics (Barcelona, Spain). This work has no connection with and is not related to the scientific interests of OneChain Immunotherapeutics. J.J.C. is a consultant for Thermo Fisher Scientific, 908 Devices and Seer. The remaining authors declare no competing interests.
